XASE
LGCY
Market cap132mUSD
Jul 09, Last price
11.67USD
1D
-0.17%
1Q
-14.19%
IPO
165.83%
Name
Legacy Education Inc
Chart & Performance
P/E
17.61
P/S
2.07
EPS
0.66
Div Yield, %
—
Shrs. gr., 5y
-3.38%
Rev. gr., 5y
31.33%
Revenues
64m
+39.49%
Net income
8m
+47.30%
CFO
8m
+371.14%
Dividend
Nov 03, 20150.15 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Legacy Education Inc. provides education services to students, high school graduates, and working parents in the United States. The company offers degree programs, including Ultrasound Technician, Cardiac Sonography, and Vocational Nursing Associate of Applied Science degree, Associate Degree of Nursing; and diploma, avocational, and certificate programs, such as Clinical Medical Assisting, Dental Assisting, Medical Administrative Assisting, Medical Billing and Coding, Pharmacy Technician, Veterinary Assistant, Vocational Nursing, Phlebotomy Technician, Magnetic Resonance Imaging, Nursing Assistant, Pit and Fissure Sealant, California Dental Practice Act, Infection Control, Radiation Safety, Teaching Adult Learner, Coronal Polishing, Dispensary Agent Certification, Vocational Nursing Pre-Requisite, LVN IV Therapy Certificate, and Emergency Medical Technician Certification. It also offers Computer Specialist: Accounting, Surgical Technology Associate of Applied Science Degree Program, Sterile Processing Technician, Computer Accounting and Business Administrative Specialist Certificate Program, Bachelor of Science in Nursing (RN to BSN), and EKG/ECG Technician programs. The company operates through academic institutions, including High Desert Medical College, Central Coast College, Contra Costa Medical Career College, and Integrity College of Health. Legacy Education Inc. was founded in 2009 and is headquartered in Lancaster, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||